Lactobacillus reuteri ATCC 55730 in Cystic Fibrosis

@inproceedings{Nardo2013LactobacillusRA,
  title={Lactobacillus reuteri ATCC 55730 in Cystic Fibrosis},
  author={Giovanni Di Nardo and Salvatore Oliva and Alessandra Menichella and Riccardo Pistelli and Riccardo Valerio De Biase},
  year={2013}
}
Objectives: The aim of this study was to evaluate in patients with cystic fibrosis (CF) the effect of Lactobacillus reuteri (LR) on the rate of respiratory exacerbations and of the infections of both upper respiratory and gastrointestinal tracts. Methods: Prospective randomized, double-blind, placebo-controlled study enrolling 61 patients with CF with mild-to-moderate lung disease at the Regional Center for CF of the Department of Pediatrics, University of Rome ‘‘La Sapienza.’’ All of the… CONTINUE READING
2
Twitter Mentions

Similar Papers

References

Publications referenced by this paper.
SHOWING 1-10 OF 61 REFERENCES

Randomised clinical trial: the effectiveness of Lactobacillus reuteri ATCC 55730 rectal enema in children with active distal ulcerative colitis

S Oliva, G Di Nardo, F Ferrari
  • Alimet Pharmacol Ther 2012;35:327–34
  • 2012
VIEW 7 EXCERPTS
HIGHLY INFLUENTIAL

Update in cystic fibrosis 2012.

  • American journal of respiratory and critical care medicine
  • 2013
VIEW 1 EXCERPT

The intestinal microbiota and chronic disorders of the gut

  • Nature Reviews Gastroenterology &Hepatology
  • 2011
VIEW 1 EXCERPT